Patent · US Active

Ophthalmic implant for delivering therapeutic substances

US10398593B2 · kind B2 · utility

2Cited by
190References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2016
Grant dateSep 3, 2019
Priority date
Expiry dateApr 20, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M39/0208
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Described are implantable therapeutic devices, systems and methods to treat a patient. The device includes a hollow refillable housing for implantation within the posterior segment of an eye through a penetration in the sclera including a proximal retention structure protruding outward from a proximal end region of the housing, an access portion opening, and a penetrable barrier positioned at least in part within the access portion opening, the penetrable barrier configured to be repeatedly penetrated. A rigid porous structure is positioned within a region of the housing away from the access portion opening into a reservoir chamber extends along an axis between the penetrable barrier and the porous structure includes a volume sized to deliver therapeutic amounts of a therapeutic agent to the eye for an extended period of time. A cover is coupled to at least an upper surface of the proximal retention structure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.